+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9o3e | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Plasmodium falciparum 20S proteasome bound to inhibitor 159 | |||||||||||||||
Components |
| |||||||||||||||
Keywords | CYTOSOLIC PROTEIN / Malaria / Plasmodium falciparum / proteasome / drug discovery / CYTOSOLIC PROTEIN-INHIBITOR complex | |||||||||||||||
| Function / homology | Function and homology informationER-Phagosome pathway / Cross-presentation of soluble exogenous antigens (endosomes) / Antigen processing: Ub, ATP-independent proteasomal degradation / Proteasome assembly / Orc1 removal from chromatin / CDK-mediated phosphorylation and removal of Cdc6 / FBXL7 down-regulates AURKA during mitotic entry and in early mitosis / KEAP1-NFE2L2 pathway / UCH proteinases / Ub-specific processing proteases ...ER-Phagosome pathway / Cross-presentation of soluble exogenous antigens (endosomes) / Antigen processing: Ub, ATP-independent proteasomal degradation / Proteasome assembly / Orc1 removal from chromatin / CDK-mediated phosphorylation and removal of Cdc6 / FBXL7 down-regulates AURKA during mitotic entry and in early mitosis / KEAP1-NFE2L2 pathway / UCH proteinases / Ub-specific processing proteases / Neddylation / Antigen processing: Ubiquitination & Proteasome degradation / MAPK6/MAPK4 signaling / ABC-family proteins mediated transport / AUF1 (hnRNP D0) binds and destabilizes mRNA / Neutrophil degranulation / proteasome core complex / proteasome endopeptidase complex / proteasome core complex, beta-subunit complex / threonine-type endopeptidase activity / proteasome core complex, alpha-subunit complex / ubiquitin-dependent protein catabolic process / endopeptidase activity / proteasome-mediated ubiquitin-dependent protein catabolic process / hydrolase activity / nucleus / cytoplasm / cytosol Similarity search - Function | |||||||||||||||
| Biological species | ![]() | |||||||||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 2.79 Å | |||||||||||||||
Authors | Han, Y. / Deng, X. / Ray, S. / Phillips, M. | |||||||||||||||
| Funding support | United States, 4items
| |||||||||||||||
Citation | Journal: J Med Chem / Year: 2025Title: Optimization of Species-Selective Reversible Proteasome Inhibitors for the Treatment of Malaria. Authors: Suraksha Gahalawat / Sneha Ray / Xiaoyu Zhang / Xiaoyi Deng / Yan Han / Zhe Chen / Aloysus Lawong / David M Shackleford / Kasiram Katneni / Gong Chen / Peng Li / Alice Ng / Longjin Zhong / ...Authors: Suraksha Gahalawat / Sneha Ray / Xiaoyu Zhang / Xiaoyi Deng / Yan Han / Zhe Chen / Aloysus Lawong / David M Shackleford / Kasiram Katneni / Gong Chen / Peng Li / Alice Ng / Longjin Zhong / Meiyu Hu / Mitchell McInerney / Wen Wang / Jessica Saunders / Daniel Collins / Jaya Jayaseelan / Cassandra L Noack / Bikash C Maity / Nirupam De / Benoît Laleu / Simon F Campbell / Margaret A Phillips / Susan A Charman / Joseph M Ready / ![]() Abstract: Malaria remains a critical global health challenge, with increasing resistance to frontline therapies necessitating novel drug targets. The proteasome has emerged as a promising target for ...Malaria remains a critical global health challenge, with increasing resistance to frontline therapies necessitating novel drug targets. The proteasome has emerged as a promising target for antimalarial drug discovery. This study describes efforts to optimize a series of species-selective reversible inhibitors targeting the 20S proteasome. Starting from the carboxypiperidine scaffold identified through a high-throughput viability screen, we conducted iterative structure-activity relationship studies, leading to the development of highly potent and selective inhibitors with good oral bioavailability. Lead compounds demonstrated nanomolar potency against blood-stage parasites and selective inhibition of the parasite proteasome over the human counterpart. Cryo-EM structural studies confirmed binding at the β5 subunit, while in vivo pharmacokinetic studies identified promising candidates for further development. These findings support proteasome inhibition as a viable strategy for novel antimalarial drug development. | |||||||||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9o3e.cif.gz | 1.2 MB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9o3e.ent.gz | Display | PDB format | |
| PDBx/mmJSON format | 9o3e.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 9o3e_validation.pdf.gz | 2 MB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 9o3e_full_validation.pdf.gz | 2 MB | Display | |
| Data in XML | 9o3e_validation.xml.gz | 154 KB | Display | |
| Data in CIF | 9o3e_validation.cif.gz | 242.6 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/o3/9o3e ftp://data.pdbj.org/pub/pdb/validation_reports/o3/9o3e | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 70077MC ![]() 9o3fC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
-Proteasome endopeptidase ... , 3 types, 6 molecules AOBPFT
| #1: Protein | Mass: 29531.656 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: Q8IAR3, proteasome endopeptidase complex #2: Protein | Mass: 26556.391 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: C6KST3, proteasome endopeptidase complex #6: Protein | Mass: 28871.697 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: Q8IK90, proteasome endopeptidase complex |
|---|
-Proteasome subunit ... , 11 types, 22 molecules CQDRESGUHVJXKYLZNbWIMa
| #3: Protein | Mass: 27977.664 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: Q8IDG3, proteasome endopeptidase complex #4: Protein | Mass: 27263.285 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: Q8IDG2, proteasome endopeptidase complex #5: Protein | Mass: 28417.367 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: Q8IBI3, proteasome endopeptidase complex #7: Protein | Mass: 29324.295 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: O77396, proteasome endopeptidase complex #8: Protein | Mass: 29143.936 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: Q8I0U7, proteasome endopeptidase complex #9: Protein | Mass: 24533.131 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: Q8I261, proteasome endopeptidase complex #10: Protein | Mass: 22889.105 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: Q8IKC9, proteasome endopeptidase complex #11: Protein | Mass: 23620.646 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: Q8IJT1, proteasome endopeptidase complex #12: Protein | Mass: 33155.211 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() #13: Protein | Mass: 25104.885 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: Q8I6T3, proteasome endopeptidase complex #14: Protein | Mass: 27301.203 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() References: UniProt: A0A5K1K7U1, proteasome endopeptidase complex |
|---|
-Non-polymers , 1 types, 2 molecules
| #15: Chemical | Mass: 427.520 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: C21H25N5O3S / Feature type: SUBJECT OF INVESTIGATION |
|---|
-Details
| Has ligand of interest | Y |
|---|---|
| Has protein modification | N |
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: Plasmodium falciparum 20S proteasome bound with inhibitor 159 Type: COMPLEX / Entity ID: #1-#14 / Source: NATURAL | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular weight | Value: 0.75 MDa / Experimental value: NO | |||||||||||||||
| Source (natural) | Organism: ![]() | |||||||||||||||
| Buffer solution | pH: 7.6 | |||||||||||||||
| Buffer component |
| |||||||||||||||
| Specimen | Conc.: 1 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES | |||||||||||||||
| Vitrification | Instrument: FEI VITROBOT MARK IV / Cryogen name: ETHANE / Humidity: 100 % / Chamber temperature: 277 K |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: FLOOD BEAM |
| Electron lens | Mode: BRIGHT FIELD / Nominal magnification: 105000 X / Nominal defocus max: 2400 nm / Nominal defocus min: 900 nm / Cs: 2.7 mm / Alignment procedure: COMA FREE |
| Specimen holder | Cryogen: NITROGEN / Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER |
| Image recording | Electron dose: 60 e/Å2 / Film or detector model: GATAN K3 BIOCONTINUUM (6k x 4k) |
| EM imaging optics | Energyfilter slit width: 20 eV |
-
Processing
| EM software |
| ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||||||||||||||
| Particle selection | Num. of particles selected: 347716 | ||||||||||||||||||||||||||||||||||||
| Symmetry | Point symmetry: C2 (2 fold cyclic) | ||||||||||||||||||||||||||||||||||||
| 3D reconstruction | Resolution: 2.79 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 45233 / Algorithm: FOURIER SPACE / Symmetry type: POINT | ||||||||||||||||||||||||||||||||||||
| Atomic model building | Space: REAL | ||||||||||||||||||||||||||||||||||||
| Atomic model building | PDB-ID: 7LXT Accession code: 7LXT / Source name: PDB / Type: experimental model | ||||||||||||||||||||||||||||||||||||
| Refinement | Highest resolution: 2.79 Å Stereochemistry target values: REAL-SPACE (WEIGHTED MAP SUM AT ATOM CENTERS) | ||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi






United States, 4items
Citation




PDBj





FIELD EMISSION GUN
